Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
Search
Close this search box.
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
Menu
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

The HD iPSC Consortium: Repeat Length Dependent Phenotypes for Assay Development

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Continue ReadingThe HD iPSC Consortium: Repeat Length Dependent Phenotypes for Assay Development

Identifying Drugs for Alzheimer’s Disease with Human Neurons Made From Human IPS cells

  • Post author:
  • Post published:May 20, 2025
  • Post category:

We propose to discover new drug candidates for Alzheimer’s Disease (AD), which is common, fatal, and for which no effective disease-modifying drugs are available. Because no effective AD treatment is…

Continue ReadingIdentifying Drugs for Alzheimer’s Disease with Human Neurons Made From Human IPS cells

Identification of Novel Therapeutics for Danon Disease Using an iPS Model of the Disease

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Autophagy is the cells mechanism for breaking down and recycling proteins. Danon disease is an inherited disorder of autophagy. Patients with this disease have major abnormalities in heart and skeletal…

Continue ReadingIdentification of Novel Therapeutics for Danon Disease Using an iPS Model of the Disease

Autologous iPSC Therapy for Urinary Incontinence

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Urinary incontinence (UI) is common and serious, with two-thirds of the burden borne by women. UI impacts both quality and length of life; women with UI suffer debilitating falls, experience…

Continue ReadingAutologous iPSC Therapy for Urinary Incontinence

Multiple Sclerosis therapy: Human Pluripotent Stem Cell-Derived Neural Progenitor Cells

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Multiple Sclerosis (MS) is a disease of the central nervous system (CNS) caused by inflammation and loss of cells that produce myelin, which normally insulates and protects nerve cells. MS…

Continue ReadingMultiple Sclerosis therapy: Human Pluripotent Stem Cell-Derived Neural Progenitor Cells

Molecules to Correct Aberrant RNA Signature in Human Diseased Neurons

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Approximately 5,600 people in the U.S. are diagnosed with ALS each year. The incidence of ALS is two per 100,000 people, and it is estimated that as many as 30,000…

Continue ReadingMolecules to Correct Aberrant RNA Signature in Human Diseased Neurons

Use of human iPS cells to study spinal muscular atrophy

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Spinal muscular atrophy (SMA) is one of the most common autosomal recessive disorders that cause infant mortality. SMA is caused by loss of the Survival of Motor Neuron (SMN) protein,…

Continue ReadingUse of human iPS cells to study spinal muscular atrophy

Correlated time-lapse imaging and single cell molecular analysis of human embryo development

  • Post author:
  • Post published:May 20, 2025
  • Post category:

We understand little about human development especially at the earliest stages. Yet human developmental biology is very important to stem cell biology and regenerative medicine for two reasons: 1) Understanding…

Continue ReadingCorrelated time-lapse imaging and single cell molecular analysis of human embryo development

Discovery of mechanisms that control epigenetic states in human reprogramming and pluripotent cells

  • Post author:
  • Post published:May 20, 2025
  • Post category:

The CIRM Basic Biology Award III was developed to support basic research that enables the realization of the full potential of human stem cells and reprogrammed cells for therapies and…

Continue ReadingDiscovery of mechanisms that control epigenetic states in human reprogramming and pluripotent cells

Investigation of synaptic defects in autism using patient-derived induced pluripotent stem cells

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Autism spectrum disorders (ASD) are a group of neurodevelopmental diseases that occur in as many as 1 in 150 children in the United States. Three hallmarks of autism are dysfunctional…

Continue ReadingInvestigation of synaptic defects in autism using patient-derived induced pluripotent stem cells
  • 1
  • 2
  • 3
  • 4
  • …
  • 33
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us